MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-WB-10-0007468
Dipika Pharmaceuticals Private Limited
Dipika Pharmaceuticals Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹44.84 Cr
▲ 8% YoY
Net profit · FY 2024
₹1.11 Cr
Net margin 2.5%
EBITDA · FY 2024
₹2.96 Cr
EBITDA margin 6.6%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹15.13 Lakh
Issued & subscribed
Open charges
₹15.83 Cr
Satisfied ₹2.1 Cr
Company age
23 yrs
Est. 2003
Employees · EPFO
33
Provident fund records
About Dipika Pharmaceuticals Private Limited
Data last updated:
Dipika Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 June 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51397WB2003PTC096389. Its GSTIN is 19AABCD8070B1ZV (West Bengal). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹15.13 Lakh. It is led by directors including Kiran Sekhar Mandal and Dipika Mandal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 164 Acharaya Jagadish Chandra Bose Road Prasad Square 5th Floor Room No – 501, Kolkata, West Bengal, India – 700014.
As per the financials filed for FY 2024, the company reported a revenue of ₹44.84 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹1.11 Cr (net margin 2.5%) and EBITDA of ₹2.96 Cr (EBITDA margin 6.6%). Revenue has grown at a compounded annual rate (CAGR) of 77% over three years and 31% over five years.
The company has about 33 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹15.83 Cr and satisfied charges of ₹2.1 Cr on record. Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it.
Dipika Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0007468). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51397WB2003PTC096389
Registration Number 096389
Incorporation Date 13 June 2003
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-WB-10-0007468
Recognitions & Rankings of Dipika Pharmaceuticals
Contact details
Dipika Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address164 Acharaya Jagadish Chandra Bose Road Prasad Square 5th Floor Room No – 501, Kolkata, West Bengal, India – 700014
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Dipika Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Dipika Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dipika Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dipika Pharmaceuticals Private Limited, buy the company report.
Financials of Dipika Pharmaceuticals Private Limited
FY 2025 filings availableDipika Pharmaceuticals Private Limited reported revenue of ₹44.84 Cr (up 8% YoY) for FY 2024.
Revenue · FY 2024
₹44.84 Cr ▲ 8%
Net profit · FY 2024
₹1.11 Cr margin 2.5%
EBITDA · FY 2024
₹2.96 Cr margin 6.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 77%
5 years · compounded
▲ 31%
EBITDA CAGR growth
1 year
▲ 61%
3 years · compounded
▲ 61%
5 years · compounded
▲ 22%
Revenue has grown at a compounded annual rate (CAGR) of 31% over five years, including 8% growth in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.96 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.11 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.6% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dipika Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dipika Pharmaceuticals Private Limited
Dipika Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kiran Sekhar Mandal | Director | 15 Jan 2018 | 8 Years 9 Months | Current |
| Dipika Mandal | Director | 13 Jun 2003 | 23 Years 4 Months | Current |
| Chandra Sekhar Mandal | Director | 13 Jun 2003 | 23 Years 4 Months | Current |
| Raj Sekhar Mandal | Director | 15 Jan 2018 | 8 Years 9 Months | Current |
Peer comparison
Dipika Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Meenakshi Medical Distributors Private Limited | ₹45.21 Cr (FY 2024) | 2.0% | Chennai, Tamil Nadu, India | |||
| Aspeya India Private Limited | ₹44.93 Cr (FY 2025) | 62.0% | Salcete, Goa, India | |||
| Dipika Pharmaceuticals Private Limitedthis company | ₹44.84 Cr (FY 2024) | ₹1.11 Cr | 2.5% | 8.0% | 33 | Kolkata, West Bengal, India |
| Aarbro Agencies Private Limited | ₹44.84 Cr (FY 2025) | 32.0% | New Delhi, Delhi, India | |||
| Able Healthcare Systems Private Limited | ₹44.8 Cr (FY 2025) | 18.0% | Chandigarh, India | |||
| Alok Medical Agencies Private Limited | ₹44.78 Cr (FY 2024) | 12.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Dipika Pharmaceuticals Private Limited, buy the company report.
Auditor
Dipika Pharmaceuticals Private Limited is audited by VRSP & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VRSP & ASSOCIATES | FY 2023 | 329490E |
Shareholding
The shareholding of Dipika Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dipika Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹15.83 Cr
Satisfied charges
₹2.1 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Apr 2025 | 101092515 | Others | ₹2.72 Cr | Open | |
| 25 May 2022 | 100584076 | Axis Bank Limited | ₹1.64 Cr | Open | |
| 31 Jan 2022 | 100531689 | Hdfc Bank Limited | ₹7 Lakh | Open | |
| 12 Nov 2021 | 100504492 | Hdfc Bank Limited | ₹1.35 Cr | Open | |
| 24 Feb 2017 | 100800913 | Axis Bank Limited | ₹96.32 Lakh | Open |
To see the full charge records of Dipika Pharmaceuticals Private Limited, buy the company report.
Total charge records: 9 View all charges
Legal cases
Dipika Pharmaceuticals Private Limited has 5 court cases on record: 1 filed by Dipika Pharmaceuticals, 4 filed against it. All cases are disposed.
Total cases
5
Filed by the company
1
Filed against the company
4
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 4 | 0 |
Cases on record (3 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed against the company by Swiss Parenterals Limited Authorised Representative Jayesh Dhanjibhai Vaghela | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Swiss Parenterals Limited Authorised Representative Jayesh Dhanjibhai Vaghela | Disposed |
| District court, South Twenty Four Parganas, West Bengal | Criminal complaint | Filed by the company against Ms. Pantagone Labs Ltd. Oth. | Disposed |
To see the full case history of Dipika Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dipika Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Dipika Pharmaceuticals Private Limited has a workforce of 33 employees on its EPFO records as of Mar 22, 2024, across 1 active EPFO establishment.
Employee count
33
Active EPFO establishments
1
Employee growth
10%
GST
Dipika Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AABCD8070B1ZV | West Bengal | Active | 01 Jul 2017 |
| 19AABCD8070B2ZU | West Bengal | Active | 25 Jun 2021 |
To see the full GST registrations and return filing status of Dipika Pharmaceuticals Private Limited, buy the company report.
Recent activity
Dipika Pharmaceuticals Private Limited has 7 board changes on record since 2003: 4 appointments and 3 cessations. The latest: Dipika Mandal ceased to be Director on 13 Dec 2024.
AGM
Dipika Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 272.00 Lakh with Charge ID 101092515 was registered on 30 Apr 2025.
Filing
Dipika Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Ceased
Dipika Mandal ceased to be Director.
Charges
A charge with Hdfc Bank Limited of Rs. 730.00 Lakh registered on 20 Feb 2017 with Charge ID 100084974 was modified on 30 Sep 2024.
Charges
A charge with Axis Bank Limited of Rs. 164.32 Lakh registered on 25 May 2022 with Charge ID 100584076 was modified on 06 Jun 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 164.32 Lakh with Charge ID 100584076 was registered on 25 May 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.00 Lakh with Charge ID 100531689 was registered on 31 Jan 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 135.08 Lakh with Charge ID 100504492 was registered on 12 Nov 2021.
Ceased
Kiran Sekhar Mandal ceased to be Additional Director.
Ceased
Raj Sekhar Mandal ceased to be Additional Director.
Appointed
Kiran Sekhar Mandal was appointed as Director.
13 earlier events are in the company report.
Frequently asked questions
Dipika Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 June 2003 (23+ years old) and is registered under CIN U51397WB2003PTC096389.
Dipika Pharmaceuticals has 4 current directors:
- Kiran Sekhar Mandal - Director
- Dipika Mandal - Director
- Chandra Sekhar Mandal - Director
- Raj Sekhar Mandal - Director
The latest financial statements of Dipika Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dipika Pharmaceuticals is 19AABCD8070B1ZV, registered in West Bengal. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 19AABCD8070B2ZU (West Bengal).
The CIN (Corporate Identification Number) of Dipika Pharmaceuticals is U51397WB2003PTC096389. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dipika Pharmaceuticals has 5 court cases on record: 1 filed by the company and 4 filed against it.
Dipika Pharmaceuticals was incorporated on 13 June 2003, making it 23+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Dipika Pharmaceuticals by revenue are Meenakshi Medical Distributors Private Limited, Aspeya India Private Limited, Aarbro Agencies Private Limited, Able Healthcare Systems Private Limited, Alok Medical Agencies Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Dipika Mandal ceased to be Director on 13 Dec 2024. Kiran Sekhar Mandal ceased to be Additional Director on 30 Sep 2018. Raj Sekhar Mandal ceased to be Additional Director on 30 Sep 2018. Dipika Pharmaceuticals has 7 board changes on record in total.
Yes, Dipika Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-WB-10-0007468).
The registered office of Dipika Pharmaceuticals is at 164 Acharaya Jagadish Chandra Bose Road Prasad Square 5th Floor Room No – 501, Kolkata, West Bengal, India – 700014.